Results 61 to 70 of about 516,470 (246)
Measurement of the branching fraction of J/ψ → ρπ at KEDR
Journal of High Energy Physics, 2023 We present the study of the decay J/ψ → ρπ. The results are based on of 5.2 million J/ψ events collected by the KEDR detector at the VEPP-4M collider.The KEDR collaboration, V. V. Anashin, O. V. Anchugov, A. V. Andrianov, K. V. Astrelina, V. M. Aulchenko, E. M. Baldin, G. N. Baranov, A. K. Barladyan, A. Yu. Barnyakov, M. Yu. Barnyakov, I. Yu. Basok, A. M. Batrakov, E. A. Bekhtenev, O. V. Belikov, D. E. Berkaev, A. E. Blinov, V. E. Blinov, M. F. Blinov, A. V. Bobrov, V. S. Bobrovnikov, A. V. Bogomyagkov, D. Yu. Bolkhovityanov, A. E. Bondar, A. R. Buzykaev, P. B. Cheblakov, V. L. Dorohov, F. A. Emanov, V. V. Gambaryan, D. N. Grigoriev, V. V. Kaminskiy, S. E. Karnaev, G. V. Karpov, S. V. Karpov, K. Yu. Karukina, D. P. Kashtankin, P. V. Kasyanenko, A. A. Katcin, T. A. Kharlamova, V. A. Kiselev, S. A. Kononov, A. A. Krasnov, E. A. Kravchenko, V. N. Kudryavtsev, V. F. Kulikov, I. A. Kuyanov, E. B. Levichev, P. V. Logachev, D. A. Maksimov, Yu. I. Maltseva, V. M. Malyshev, A. L. Maslennikov, O. I. Meshkov, S. I. Mishnev, I. A. Morozov, I. I. Morozov, D. A. Nikiforov, S. A. Nikitin, I. B. Nikolaev, I. N. Okunev, S. B. Oreshkin, A. A. Osipov, I. V. Ovtin, A. V. Pavlenko, S. V. Peleganchuk, P. A. Piminov, N. A. Podgornov, V. G. Prisekin, O. L. Rezanova, A. A. Ruban, G. A. Savinov, A. G. Shamov, L. I. Shekhtman, D. A. Shvedov, B. A. Shwartz, E. A. Simonov, S. V. Sinyatkin, A. N. Skrinsky, A. V. Sokolov, E. V. Starostina, D. P. Sukhanov, A. M. Sukharev, A. A. Talyshev, V. A. Tayursky, V. I. Telnov, Yu. A. Tikhonov, K. Yu. Todyshev, A. G. Tribendis, G. M. Tumaikin, Yu. V. Usov, A. I. Vorobiov, V. N. Zhilich, A. A. Zhukov, V. V. Zhulanov, A. N. Zhuravlev +94 moredoaj +1 more sourceRecent results from CMD-3 [PDF]
EPJ Web of Conferences, 2019 Regular data taking with the CMD-3 at the electron-positron collider VEPP-2000 is under way since 2010. The collected data sample corresponds to about 200 inverse picobarns of integrated luminosity per detector in the energy range from 0.32 up to 2 GeV ...Ignatov F. V., Akhmetshin R. R., Amirkhanov A. N., Anisenkov A. V., Aulchenko V. M., Banzarov V. Sh., Bashtovoy N. S., Berkaev D. E., Bondar A. E., Bragin A. V., Eidelman S. I., Epifanov D. A., Epshteyn L. B., Erofeev A. L., Fedotovich G. V., Gayazov S. E., Grebenuk A. A., Gribanov S. S., Grigoriev D. N., Ivanov V. L., Karpov S. V., Kazanin V. F., Koop I. A., Kirpotin A. N., Korobov A. A., Kozyrev A. N., Kozyrev E. A., Krokovny P. P., Kuzmenko A. E., Kuzmin A. S., Logashenko I. B., Lukin P. A., Mikhailov K. Yu., Okhapkin V. S., Pestov Yu. N., Popov A. S., Razuvaev G. P., Rogovsky Yu. A., Ruban A. A., Ryskulov N. M., Ryzhenenkov A. E., Semenov A. V., Shatunov Yu. M., Shatunov P. Yu., Shebalin V. E., Shemyakin D. N., Shwartz B. A., Shwartz D. B., Sibidanov A. L., Solodov E. P., Titov V. M., Talyshev A. A., Vorobiov A. I., Zemlyansky I. M., Yudin Yu. V. +54 moredoaj +1 more sourceSubclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic Impact
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives
We aimed to determine the frequency of subclinical optic nerve (ON) lesions using MRI, optical coherence tomography (OCT), and visual evoked potentials (VEP) in radiologically isolated syndrome (RIS), and to assess their diagnostic and prognostic significance.Christine Lebrun‐Frenay, Cassandre Landes‐Château, Lydiane Mondot, Mikael Cohen, Margherita Popolo, Jérôme de Seze, Bertrand Bourre, Françoise Durand‐Dubief, Olivier Casez, Orhun H. Kantarci, Aksel Siva, Stephanie Baillif, Darin T. Okuda, Letizia Leocani +13 morewiley +1 more sourceCMD-3 Overview [PDF]
EPJ Web of Conferences, 2019 The CMD-3 detector is installed at the VEPP-2000 e+e− collider at BINP (Novosibirsk, Russia). It is a general-purpose detector, equipped with a tracking system, two crystal (CSI and BGO) calorimeters, liquid Xe calorimeter, TOF and muon systems. The main Logashenko Ivan B., Ignatov F.V., Akhmetshin R.R., Amirkhanov A.N., Anisenkov A.V., Aulchenko V.M., Banzarov V.S., Bashtovoy N.S., Berkaev D.E., Bondar A.E., Bragin A.V., Eidelman S.I., Epifanov D.A., Epshteyn L.B., Erofeev A.L., Fedotovich G.V., Gayazov S.E., Grebenuk A.A., Gribanov S.S., Grigoriev D.N., Ivanov V.L., Karpov S.V., Kazanin V.F., Kirpotin A.N., Korobov A.A., Koop I.A., Kozyrev A.N., Kozyrev E.A., Krokovny P.P., Kuzmenko A.E., Kuzmin A.S., Lukin P.A., Mikhailov K.Yu., Okhapkin V.S., Otboev A.V., Pestov Yu.N., Popov A.S., Razuvaev G.P., Ruban A.A., Ryskulov N.M., Ryzhenenkov A.E., Senchenko A.I., Shebalin V.E., Shemyakin D.N., Shwartz B.A., Shwartz D.B., Sibidanov A.L., Shatunov P.Yu., Shatunov Yu.M., Solodov E.P., Talyshev A.A., Vorobiov A.I., Yudin Yu.V., Zemlyansky I.M. +53 moredoaj +1 more sourceNeurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...James M. Joers, Yaqiao Wei, Dinesh K. Deelchand, Adam Berrington, Young Woo Park, Guita Banan, Michal Povazan, Jens T. Rosenberg, André J. W. van der Kouwe, Tetsuo Ashizawa, Khalaf O. Bushara, Chiadi U. Onyike, Sub H. Subramony, Jeremy D. Schmahmann, Brian J. Soher, Peter B. Barker, Thomas H. Mareci, Eva‐Maria Ratai, Lynn E. Eberly, Gülin Öz +19 morewiley +1 more source
